Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10499545Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pathology
NIH Funding · FY2026
Linked Award Amount
$1.1M
Full award amounts, FY2026
Award Records
2
Records listing this PI
Award-Linked Rank
#8,079
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Weizhou Zhang as a PI. Multi-PI records show the full award amount for context.
- 5R01CA290792-03R01Proteolysis targeting chimera against nuclear receptor NR4A1 for melanoma therapy$645.6Kaward amount
- 5R01CA269661-04R01Exploring novel therapeutic strategies for combinatory therapy to treat renal clear cell carcinomas$501.7Kaward amount
Award organization
Organizations that administered FY2026 awards listing Weizhou Zhang as a PI.
FY2026 award administered by University of Florida (FL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Florida
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #7888
- 2025$2M Cumulative Funding
- 2025R01 Grant Holder
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Weizhou Zhang.